Samantha Visits 1 - 4: An African-American woman with HIV

Title:

Samantha Visits 1 - 4: An African-American woman with HIV

Topic: Infectious Diseases
Relevant Terms: Cardiometabolic Syndrome, Hepatitis C, Patient Adherence, Pregnancy
Primary Audience: This activity is intended for infectious disease specialists; HIV/AIDS clinicians; HIV specialists; primary care physicians (family and internal medicine physicians); residents/fellows; and other health care providers managing patients with HIV infection.
Launch Date: 19-Oct-12
Credits: 0.5 AMA PRA Category 1 Credit
Expiration Date: The accreditation for this activity has expired.
Curriculum Name: Samantha: A Life with HIV - Optimizing Therapy in HIV

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Monitor and improve adherence to ARV therapy for patients infected with HIV, particularly patients younger than 25
  2. Optimally manage the treatment of women of childbearing age who are infected with HIV, including antiretroviral therapy, patient counseling, and bone disease treatment
  3. State the key considerations in using novel direct-acting antiviral agents for HCV in patients with HIV/HCV coinfections, including risks for drug-drug interactions and overlapping toxicities, and when and in whom to delay initiation of therapy
  4. Identify common comorbidities in older adults with HIV and delineate key treatment considerations in these patients

    Faculty

    GLENN J. TREISMAN, MD (Course Director)
    Professor of Psychiatry, Behavioral Sciences,
    and Internal Medicine
    Director, AIDS Psychiatry Service
    The Johns Hopkins University School of Medicine
    Baltimore, Maryland
    JOHN G. BARTLETT, MD
    Professor of Medicine
    Director, HIV Care Program
    The Johns Hopkins University School of Medicine
    Baltimore, Maryland
    JEAN RENE ANDERSON, MD
    Professor of Gynecology and Obstetrics
    Director, Division of Gynecologic Specialties
    The Johns Hopkins University School of Medicine
    Baltimore, Maryland
    MARK SULKOWSKI, MD (Planning Committee)
    Professor of Medicine Medical Director, Viral Hepatitis Center
    Divisions of Infectious Diseases and Gastroenterology/Hepatology
    The Johns Hopkins University School of Medicine
    Baltimore, Maryland
     
    Presented by the Johns Hopkins University School of Medicine

    Supported by an educational grant from Bristol-Myers Squibb

    ACCREDIATION STATEMENT
    The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    CREDIT DESIGNATION
    The Johns Hopkins University School of Medicine designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credits™. In order to receive a Certificate of Credit, physicians must attest to the number of hours they have actually participated in this activity. Please attest to the amount of time you spent on this activity, in increments of 0.25 credit hours/15 minutes.

    Length of activity: 30 minutes 

    METHOD OF PARTICIPATION
    There are no fees for participating in this CME activity. To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) complete the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section

    SUCESSFUL COMPLETION
    To take the post-test for Samantha: A Life with HIV you will need to click here, and have a passing grade of 70% or higher on the post-test to receive credit.

    RELEASE DATE
    Date of release: October 19, 2012
    Expiration date: October 18, 2013
     
    INTENDED AUDIENCE 
    This activity is intended for infectious disease specialists, HIV specialists, primary care physicians (family and internal medicine physicians), HIV/AIDS clinicians, residents/fellows, and other health care providers who manage patients with HIV infections.
     
    STATEMENT OF NEED
    Through a review of the current literature, including national and regional measures, recent professional guidelines, detailed conversations with expert educators, and a survey of practicing clinicians treating patients with HIV, the following core learning gaps have been identified:
    • Clinicians require effective strategies to monitor and optimize adherence to medical care for patients with HIV, particularly in specific populations such as younger patients, pregnant women, coinfected patients, and those with mental disorders.
    • The demographics of HIV have shifted to include many older adults, and clinicians require education regarding the treatment of common comorbidities in older patients who are also infected with HIV.
    • Clinicians may be uncertain about issues specific to treating women with HIV, such as the optimal timing of initiation and dosing of ARV therapy, concerns regarding conception and pregnancy, and monitoring and treating bone disease.
    • Many clinicians require education on the optimal timing and use of new hepatitis C medications in patients coinfected with HIV/HCV.
    STATEMENT OF RESPONSIBILITY
    The Johns Hopkins University School of Medicine takes responsibility for the content, quality and scientific integrity of this CME activity.

    DISCLAMER
    The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of The Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
     
    INTERNET CME POLICY
    The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protecting the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public.

    Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet-based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services that you request.

    MEDIUM
    The Internet was selected as the instructional format to accommodate the learning preferences of a significant portion of the target audience.

    HARDWARE AND SOFTWARE REQUIREMENTS
    Pentium 800 processor or greater, Windows 98/NT/2000/XP/7 or Mac OS 9/X, Microsoft Internet Explorer 5.5 or later, 56K or better modem, Windows Media Player 9.0 or later, 128 MB of RAM, sound card and speakers, Adobe Acrobat Reader, storage, Internet connectivity, and minimum connection speed. Monitor settings: High color at 800 x 600 pixels
     
     
    CONFIDENTIALITY DISCLAIMER FOR CME CONFERENCE ATTENDEES
    I certify that I am attending a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.
     
    I understand that while I am attending in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations").

    I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential.
     
    I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.

    "The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only."

    For CME Questions, please contact the CME Office at (410) 955-2959 or e-mail cmenet@jhmi.edu.

    For CME Certificates, please call (410) 502-9634.

    Johns Hopkins University School of Medicine Office of Continuing Medical Education
    Turner 20/720 Rutland Avenue
    Baltimore, Maryland 21205-2195
     
    Reviewed & Approved by:
    General Counsel, Johns Hopkins Medicine (4/1/03)
    Updated 4/09
     
    Planner Disclosure
    Mark S. Sulkowski, MD
    Grant/Research Support: Abbott, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers
    Squibb, Gilead, Janssen, Merck, Roche, and Vertex Pharmaceuticals.
    Consultant: Abbott, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb,
    Gilead, Janssen, Merck, Pfizer, Roche, and Vertex Pharmaceuticals

    No other planners have indicated that they have any financial interests or relationships with a commercial entity.

    Speaker Disclosure
    Mark S. Sulkowski, MD
    Grants/Research Support: Abbott, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb, Gilead, Janssen, Merck, Roche, and Vertex Pharmaceuticals
    Consultant: Abbott, Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb, Gilead, Janssen, Merck, Pfizer, Roche, and Vertex Pharmaceuticals

    Lecture Title: Samantha: Age 36—Coinfection

    No other faculty members have indicated that they have any financial interests or relationships with a commercial entity whose products or services are relevant to the content of their presentation(s).

    Off-LABEL PRODUCT DISCUSSION
    The following speakers have disclosed that their presentation will reference unlabeled/unapproved uses of drugs or products:
    Mark S. Sulkowski, MD
    Samantha: Age 36—Coinfection
    telaprevir and boceprevir
     
    No other speakers have indicated that they will reference unlabeled/unapproved uses of drugs or products.

    ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT
    Supported by an educational grant from Bristol-Myers Squibb.

    To participate in additional CME activities presented by the Johns Hopkins University School of Medicine Continuing Medical Education Office, please visit www.hopkinscme.edu
     
    © All rights reserved. The Johns Hopkins University School of Medicine 
     
    Presented by JHUSOM in collaboration with DKBmed.